Paloma Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-24,992
| Closed | -$50K | – | 2057 |
|
|
2020
Q2 | $50K | Buy |
+24,992
| New | +$50K | ﹤0.01% | 1796 |
|
|
2019
Q4 | – | Sell |
-42,800
| Closed | -$129K | – | 1978 |
|
|
2019
Q3 | $129K | Buy |
+42,800
| New | +$129K | ﹤0.01% | 1488 |
|
|
2019
Q2 | – | Sell |
-15,903
| Closed | -$88K | – | 1668 |
|
|
2019
Q1 | $88K | Buy |
15,903
+4,903
| +45% | +$27.1K | ﹤0.01% | 1271 |
|
|
2018
Q4 | $73K | Buy |
+11,000
| New | +$73K | ﹤0.01% | 895 |
|
|
2017
Q4 | – | Sell |
-69,521
| Closed | -$854K | – | 1471 |
|
|
2017
Q3 | $854K | Buy |
69,521
+9,307
| +15% | +$114K | 0.01% | 721 |
|
|
2017
Q2 | $991K | Sell |
60,214
-10,458
| -15% | -$172K | 0.01% | 784 |
|
|
2017
Q1 | $1.01M | Buy |
70,672
+12,967
| +22% | +$186K | 0.01% | 813 |
|
|
2016
Q4 | $798K | Buy |
+57,705
| New | +$798K | 0.01% | 876 |
|
|
2014
Q3 | – | Sell |
-2,611
| Closed | -$29K | – | 1096 |
|
|
2014
Q2 | $29K | Buy |
+2,611
| New | +$29K | ﹤0.01% | 986 |
|